Effectiveness and safety of the conversion to MeltDose


Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
01 2020
Historique:
received: 28 05 2019
revised: 14 11 2019
accepted: 25 11 2019
pubmed: 10 12 2019
medline: 24 6 2021
entrez: 10 12 2019
Statut: ppublish

Résumé

Tacrolimus is the cornerstone of immunosuppressive therapy after kidney transplantation. Its narrow therapeutic window mandates serum level strict monitoring and dose adjustments to ensure the optimal risk-benefit balance. This observational retrospective study analyzed the effectiveness and safety of conversion from twice-daily immediate-release tacrolimus (IR-Tac) or once-daily prolonged-release tacrolimus (PR-Tac) to the recent formulation once-daily MeltDose

Identifiants

pubmed: 31815310
doi: 10.1111/ctr.13767
pmc: PMC7050537
doi:

Substances chimiques

Delayed-Action Preparations 0
Immunosuppressive Agents 0
Tacrolimus WM0HAQ4WNM

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13767

Informations de copyright

© 2019 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.

Références

Clin Transplant. 2018 Aug;32(8):e13311
pubmed: 29888809
Exp Clin Transplant. 2018 Jun;16(3):321-325
pubmed: 28697715
J Biopharm Stat. 1996 Nov;6(4):411-24
pubmed: 8969977
Transplant Proc. 2016 Mar;48(2):420-3
pubmed: 27109969
Clin Transplant. 2020 Jan;34(1):e13767
pubmed: 31815310
Am J Transplant. 2013 Mar;13(3):760-9
pubmed: 23279614
JAMA. 2013 Nov 27;310(20):2191-4
pubmed: 24141714
BMJ. 2005 Oct 8;331(7520):810
pubmed: 16157605
Adv Chronic Kidney Dis. 2016 Sep;23(5):281-286
pubmed: 27742381
Am J Transplant. 2014 Dec;14(12):2796-806
pubmed: 25278376
Expert Rev Clin Immunol. 2014 Dec;10(12):1567-79
pubmed: 25407098
Transplantation. 2013 Jul 27;96(2):191-7
pubmed: 23715050
Transplant Res. 2014 Mar 10;3(1):7
pubmed: 24606676
Transplantation. 2013 Jan 27;95(2):333-40
pubmed: 23263559
Am J Transplant. 2017 Feb;17(2):432-442
pubmed: 27340950
Transplantation. 2007 Apr 15;83(7):858-73
pubmed: 17460556
Transpl Int. 2012 Mar;25(3):283-93
pubmed: 22239105
Adv Ther. 2019 Feb;36(2):462-477
pubmed: 30552587
Liver Transpl. 2014 May;20(5):564-75
pubmed: 24493215
Drugs. 2015 Feb;75(3):309-20
pubmed: 25613762
Clin Transplant. 2015 Sep;29(9):796-805
pubmed: 26113208
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Clin Pharmacokinet. 2015 Oct;54(10):993-1025
pubmed: 26038096
World J Gastroenterol. 2013 Dec 28;19(48):9156-73
pubmed: 24409044
Transplantation. 2004 Mar 15;77(5):769-76
pubmed: 15021846
Transpl Int. 2016 May;29(5):603-11
pubmed: 26953629
Clin Ther. 2002 Mar;24(3):330-50; discussion 329
pubmed: 11952020
Transplant Rev (Orlando). 2017 Jan;31(1):10-17
pubmed: 28340885
Immunopharmacology. 2000 May;47(2-3):63-83
pubmed: 10878284

Auteurs

Ana Sánchez Fructuoso (A)

Nephrology, University Hospital Clínico San Carlos, Madrid, Spain.

Juan Carlos Ruiz (JC)

Nephrology, University Hospital Marqués de Valdecilla, Santander, Spain.

Antonio Franco (A)

Nephrology, University Hospital General, Alicante, Spain.

Fritz Diekmann (F)

Nephrology, University Hospital Clinic, Barcelona, Spain.

Dolores Redondo (D)

Nephrology, University Hospital del Mar, Barcelona, Spain.

Jesús Calviño (J)

Nephrology, Hospital Lucus Augusti, Lugo, Spain.

Nuria Serra (N)

Nephrology, Fundación Puigvert, Barcelona, Spain.

María José Aladrén (MJ)

Nephrology, Hospital Miguel Servet, Zaragoza, Spain.

Secundino Cigarrán (S)

Nephrology, Hospital da Costa, Burela, Lugo, Spain.

Ana Manonelles (A)

Nephrology, University Hospital Bellvitge, Hospitalet de Llobregat, Spain.

Ana Ramos (A)

Nephrology, Fundación Jiménez Díaz, Madrid, Spain.

Gonzalo Gómez (G)

Nephrology, University Hospital son Espases, Palma de Mallorca, Spain.

José Manuel González Posada (JM)

Nephrology, University Hospital Nuestra Señora de la Candelaria, Santa Cruz de Tenerife, Spain.

Amado Andrés (A)

Nephrology, University Hospital Doce de Octubre, Madrid, Spain.

Isabel Beneyto (I)

Nephrology, University Hospital La Fe, Valencia, Spain.

Andrés López Muñiz (AL)

Nephrology, University Hospital A Coruña, La Coruña, Spain.

Manel Perelló (M)

Nephrology, University Hospital Vall de Hebrón, Barcelona, Spain.

Ricardo Lauzurica (R)

Nephrology, University Hospital Germans Trias y Pujol, Badalona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH